This activity is intended for Endocrinologists, Diabetologists, and Certified Diabetes care and Education Specialists (CDCESs) who are involved in caring for individuals with Type 2 Diabetes (T2D). 

At the end of this educational initiative, learners will be able to:

• Assess the mechanism of action, efficacy, safety, route of administration, and dosing optimization for approved glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and GLP-1/glucose-dependent insulinotropic polypeptide (GIP) RAs for the management of type 2 diabetes
• Identify the extra-glycemic benefits of GLP-1 RAs for patients with comorbidities
• Incorporate GLP-1 RAs into the management of type 2 diabetes based on evidence-based guidelines, patient and drug characteristics, and patient preference

In support of improving patient care, Medical Learning Institute Inc is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

This activity is provided by MLI

Physician Continuing Medical Education

Medical Learning Institute Inc (MLI) designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Certified Diabetes Care and Education Specialists

To satisfy the requirements for renewal of certification for the Certification Board for Diabetes Care and Education (CBDCE), continuing education activities must be diabetes related and approved by a provider on the CBDCE list of Approved Providers (www.ncbde.org). CBDCE does not approve continuing education. The Association of Diabetes Care & Education Specialists (ADCES) is on the CBDCE list of approved providers.

This content was developed in collaboration with Medical Learning Institute Inc and ADCES to support the continuing education of diabetes care and education specialists.

Nursing Continuing Professional Development

Successful completion of this nursing continuing professional development activity will be awarded 1.5 contact hour(s) and 1.5 contact hour(s) in the area of pharmacology.

Dietitian Continuing Professional Education Units (CPEUs)

Medical Learning Institute Inc is a Continuing Professional Education (CPE) Accredited provider with the Commission on Dietetic Registration (CDR).  

CDR Credentialed Practitioners will receive 1.5 Continuing Professional Education units (CPEUs) for completion of this activity/material.  

Medical Learning Institute Inc is committed to providing high quality continuing education to healthcare professionals, as individuals and teams, with a protected space to learn, teach, and engage in scientific discourse free from influence from ineligible companies that may have an incentive to insert commercial bias into education. To that end, MLI requires faculty, presenters, planners, staff, and other individuals who are in a position to control the content of this CE activity to disclose all financial relationships they have had in the past 24 months with ineligible companies as defined by the ACCME, as related to the content of this CE activity, regardless of the amount or their view of the relevance to the education. All identified COI will be thoroughly vetted and mitigated according to MLI policy. These disclosures will be provided to learners prior to the start of the CE activity.

Faculty Disclosures

Chair/Planner/Presenter  
Jennifer B. Green, MD 
Professor of Medicine 
Division of Endocrinology 
Duke University School of Medicine 
Durham, NC, USA 

Jennifer B. Green, MD, has a financial interest/relationship or affiliation in the form of:
Consultant/Advisor: Anji, AstraZeneca, Bayer, Boehringer Ingelheim, Corcept, Lilly, Merck, Mineralys, Novo Nordisk, Sanofi, Valo, Vertex
Research Funding: Bluedrop (ended), Boehringer Ingelheim, Lilly, Merck, Roche

Planner/Presenter  
Jennifer Goldman, PharmD, CDCES, BC-ADM FCCP 
Professor of Pharmacy Practice 
Massachusetts College of Pharmacy and Health Sciences 
Clinical Pharmacist, Director of Cardiometabolic Service 
Well Life Medical 
Boston, MA, USA 

Jennifer Goldman, PharmD, CDCES, BC-ADM FCCP, has a financial interest/relationship or affiliation in the form of: 
Consultant/Advisor:  Abbott Diabetes, Amgen, CeQur, Lilly, Novo Nordisk, Xeris 
Other: Stock Shares: Abbott, Lilly, Novo Nordisk 

Planner/Presenter  
Jay H. Shubrook, DO, FACOFP, FAAFP 
Professor, Diabetologist 
Department of Clinical Sciences and Community Health 
Touro University California, College of Osteopathic Medicine 
Vallejo, CA, USA 

Jay H. Shubrook, DO, FACOFP, FAAFP, has a financial interest/relationship or affiliation in the form of: 
Consultant/Advisor: Abbott, Bayer, Eli Lilly, Madrigal, Novo Nordisk, Sanofi 
Other: Member of American Diabetes Association, American College of Diabetology (Chair of the Executive Board), American College of Osteopathic Family Physicians, American Academy of Family Physicians, American Osteopathic Association and the Global NASH Council. 
The following relationships have ended within the last 24 months: 
Consultant/Advisor: Nevro (ended 6/2023) 

All of the relevant financial relationships of individuals for this activity have been mitigated. 

Planning Committee and Content/Peer Reviewers

The planners and content/peer reviewers from Medical Learning Institute Inc, the accredited provider, do not have any relevant financial relationships to disclose with ineligible companies unless listed below.

Disclosure of Unlabeled Use

This educational activity may contain discussions of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this CE activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the CE activity are those of the presenters and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this CE activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this CE activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Method of Participation

There are no fees for participating in or receiving credit for this CE activity.  In order to receive credit, learners must participate in the entire CE activity, complete the activity evaluation form and your certificate of credit will be generated. You will receive your certificate from Medical Learning Institute Inc.

For information on applicability and acceptance of continuing education credit for this CE activity, please consult your professional licensing board.

If you have questions regarding your certificate, please contact MLI at mvu@mlieducation.org.

About This Activity

Medical Learning Institute Inc is responsible for the selection of this activity’s topics, the preparation of editorial content, and the distribution of this CE activity. Our activities may contain references to unapproved products or uses of these products in certain jurisdictions. The preparation of this activity is supported by educational grants subject to written agreements that clearly stipulate and enforce the editorial independence of Medical Learning Institute Inc.

The materials presented here are used with the permission of the authors and/or other sources. These materials do not necessarily reflect the views of Medical Learning Institute Inc or any of its partners, providers, and/or supporters.

Copyright © 2025 Medical Learning Institute Inc. All Rights Reserved.